These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 16982835)

  • 61. Monocyte chemoattractant protein 1 contributes to an adequate immune response in influenza pneumonia.
    Dessing MC; van der Sluijs KF; Florquin S; van der Poll T
    Clin Immunol; 2007 Dec; 125(3):328-36. PubMed ID: 17827068
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CD11b limits bacterial outgrowth and dissemination during murine pneumococcal pneumonia.
    Rijneveld AW; de Vos AF; Florquin S; Verbeek JS; van der Poll T
    J Infect Dis; 2005 May; 191(10):1755-60. PubMed ID: 15838804
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia.
    van Zoelen MA; Schouten M; de Vos AF; Florquin S; Meijers JC; Nawroth PP; Bierhaus A; van der Poll T
    J Immunol; 2009 Apr; 182(7):4349-56. PubMed ID: 19299735
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pneumonia models and innate immunity to respiratory bacterial pathogens.
    Knapp S; Schultz MJ; van der Poll T
    Shock; 2005 Dec; 24 Suppl 1():12-8. PubMed ID: 16374367
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Novel chemokine responsiveness and mobilization of neutrophils during sepsis.
    Speyer CL; Gao H; Rancilio NJ; Neff TA; Huffnagle GB; Sarma JV; Ward PA
    Am J Pathol; 2004 Dec; 165(6):2187-96. PubMed ID: 15579460
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Essential contribution of monocyte chemoattractant protein-1/C-C chemokine ligand-2 to resolution and repair processes in acute bacterial pneumonia.
    Amano H; Morimoto K; Senba M; Wang H; Ishida Y; Kumatori A; Yoshimine H; Oishi K; Mukaida N; Nagatake T
    J Immunol; 2004 Jan; 172(1):398-409. PubMed ID: 14688348
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies.
    Daly C; Rollins BJ
    Microcirculation; 2003 Jun; 10(3-4):247-57. PubMed ID: 12851642
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cytokines in innate host defense in the lung.
    Strieter RM; Belperio JA; Keane MP
    J Clin Invest; 2002 Mar; 109(6):699-705. PubMed ID: 11901175
    [No Abstract]   [Full Text] [Related]  

  • 69. IL-18 improves the early antimicrobial host response to pneumococcal pneumonia.
    Lauw FN; Branger J; Florquin S; Speelman P; van Deventer SJ; Akira S; van der Poll T
    J Immunol; 2002 Jan; 168(1):372-8. PubMed ID: 11751983
    [TBL] [Abstract][Full Text] [Related]  

  • 70. TNF-alpha compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia.
    Rijneveld AW; Florquin S; Branger J; Speelman P; Van Deventer SJ; van der Poll T
    J Immunol; 2001 Nov; 167(9):5240-6. PubMed ID: 11673538
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Role of chemokines and formyl peptides in pneumococcal pneumonia-induced monocyte/macrophage recruitment.
    Fillion I; Ouellet N; Simard M; Bergeron Y; Sato S; Bergeron MG
    J Immunol; 2001 Jun; 166(12):7353-61. PubMed ID: 11390486
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Induction of cell-associated chemokines after endotoxin administration to healthy humans.
    Olszyna DP; De Jonge E; Dekkers PE; van Deventer SJ; van der Poll T
    Infect Immun; 2001 Apr; 69(4):2736-8. PubMed ID: 11254644
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: cross-talk between MCP-1 and leukotriene B4.
    Matsukawa A; Hogaboam CM; Lukacs NW; Lincoln PM; Strieter RM; Kunkel SL
    J Immunol; 1999 Dec; 163(11):6148-54. PubMed ID: 10570305
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Commentary on the 1993 American Thoracic Society guidelines for the treatment of community-acquired pneumonia.
    Campbell GD
    Chest; 1999 Mar; 115(3 Suppl):14S-18S. PubMed ID: 10084454
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treatment of community-acquired pneumonia--IDSA guidelines. Infectious Diseases Society of America.
    Bernstein JM
    Chest; 1999 Mar; 115(3 Suppl):9S-13S. PubMed ID: 10084453
    [TBL] [Abstract][Full Text] [Related]  

  • 76. MCP-1 protects mice in lethal endotoxemia.
    Zisman DA; Kunkel SL; Strieter RM; Tsai WC; Bucknell K; Wilkowski J; Standiford TJ
    J Clin Invest; 1997 Jun; 99(12):2832-6. PubMed ID: 9185504
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice.
    van der Poll T; Keogh CV; Buurman WA; Lowry SF
    Am J Respir Crit Care Med; 1997 Feb; 155(2):603-8. PubMed ID: 9032201
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice.
    Takashima K; Tateda K; Matsumoto T; Iizawa Y; Nakao M; Yamaguchi K
    Infect Immun; 1997 Jan; 65(1):257-60. PubMed ID: 8975920
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interleukin-10 impairs host defense in murine pneumococcal pneumonia.
    van der Poll T; Marchant A; Keogh CV; Goldman M; Lowry SF
    J Infect Dis; 1996 Nov; 174(5):994-1000. PubMed ID: 8896500
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Monocyte chemotactic protein 1 is released during lethal and sublethal bacteremia in baboons.
    Jansen PM; van Damme J; Put W; de Jong IW; Taylor FB; Hack CE
    J Infect Dis; 1995 Jun; 171(6):1640-2. PubMed ID: 7769308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.